Contraindicated in:
Obstetrical paracervical block anesthesia
.Use Cautiously in:
CV: arrhythmias, bradycardia, CARDIOVASCULAR COLLAPSE, hypotension
Derm: pruritus
EENT: blurred vision, tinnitus
F and E: metabolic acidosis
Hemat: methemoglobinemia
Neuro: anxiety, circumoral tingling/numbness, dizziness, dysgeusia, headache, irritability, SEIZURES, tremor
Misc: fever, allergic reactions
Drug-drug:
Absorption: Systemic absorption follows epidural administration, but amount absorbed depends on dose.
Distribution: If systemic absorption occurs, this agent is widely distributed and crosses the placenta.
Half-Life: 1.55 hr (after epidural use).
Advise women of reproductive potential to notify health care professional if pregnancy is planned or suspected or if breastfeeding. Bupivacaine use has resulted in fetal bradycardia and death; its use is not recommended for use in obstetrical anesthesia. If used after risk/benefit analysis, monitor the fetal HR continuously during labor and delivery.
NDC Code